09:22 AM EDT, 05/08/2025 (MT Newswires) -- Vericel ( VCEL ) reported a Q1 loss Thursday of $0.23 per diluted share, widening from a loss of $0.08 a year earlier.

Analysts polled by FactSet expected a loss of $0.12.

Total net revenue for the quarter ended March 31 was $52.6 million, up from $51.3 million a year earlier.

Analysts surveyed by FactSet expected $53.8 million.

For Q2, the biopharmaceutical company said it expects total revenue to increase by 22% to 25%.

For 2025, the company said it continues to expect revenue to increase 20% to 23%.

The company said it had cash, restricted cash and investments of about $162 million as of March 31, and no debt.

Shares were 6.5% lower ahead of Thursday's opening bell.